Navigation Links
Coalition for a Competitive Pharmaceutical Market Launches New Print Ad Campaign Highlighting Need for Meaningful Biogenerics Legislation
Date:2/14/2008

'Countless Patients Cannot Afford Life-Saving Biopharmaceuticals'

WASHINGTON, Feb. 14 /PRNewswire-USNewswire/ -- As part of its campaign to enact meaningful biogenerics legislation that would create a pathway for FDA approval of safe and effective biogenerics, CCPM unveiled a new print advertisement that features a footprint in the snow stating: "Don't Leave Patients Out in the Cold."

The ad highlights how meaningful biogenerics legislation should be balanced to foster innovation without excessive and unprecedented market exclusivity that simply extends brand monopolies. Such legislation would be an empty promise for patients.

In addition, CCPM released letters to the Administration and to the House Energy & Commerce Committee Leadership stressing the need for biologics legislation that provides a meaningful FDA pathway and not a pathway in name only.

CCPM supports public policies that facilitate timely access to affordable pharmaceuticals. Visit http://www.competitiverx.com for more information and a list of CCPM members.

Contact: Katie Braden Huffard, 202-255-5216;

Andrea Hofelich, 703-647-2495; Charles Cote, 202-207-3605


'/>"/>
SOURCE CCPM
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
2. Agendia Joins the Personalized Medicine Coalition (PMC)
3. New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October 1-2 in NJ
4. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
5. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
6. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
7. Technology Transforms Market Research in Pharmaceutical Industry
8. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast
9. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
10. Vion Pharmaceuticals Holds Special Meeting of Stockholders
11. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... RPS Diagnostics (RPS®) – ... announced that Robert A. Gregg, PhD, has joined RPS as Senior Vice President ... relevant experience and remarkable achievements in the medical device and diagnostics industries. , ...
(Date:8/4/2015)... ... August 04, 2015 , ... On August 4, 2015, the White House will ... from across the United States to talk about their experiences with innovation and present ... to be among the attendees. , One of the day’s aims is to grow ...
(Date:8/3/2015)... , Aug. 3, 2015  ArroGen Group, ... its new Fingerprint Molecular Identification™ (FMID) technology Aug. ... conference in Sacramento, Calif. ... science, will enable law enforcement agents, district attorneys ... of criminal suspects. By analyzing chemical ...
(Date:8/3/2015)... , Aug. 3, 2015  Merck KGaA, Darmstadt, ... innovative and top-quality high-tech products in the healthcare, life ... the US-based company Nano-C, their development and launch of ... organic photovoltaics (OPV). Merck KGaA, Darmstadt, Germany ... the growing OPV sector. Novel derivatives: highly ...
Breaking Biology Technology:RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2ArroGen Previews New Fingerprint Molecular Identification Technology 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4
... , , , , Guy Adami, ... , Vincent Prezioso, Eppendorf Scientific, Inc., Westbury, NY, USA , ... , , Transgenic ... into their genome. The most common method of introducing recombinant DNA , ...
... , , , , Bodo ... Borstel, Parkallee 22, , D-23845 Borstel, Germany. , ... , , Abstract ... enhancer for , improving PCR efficiency: the TaqMaster. With this ...
... , , , , Christian ... , Lars-Erik Peters, Eppendorf 5Prime, USA , ... The reliability of a PCR* experiment is dependent on its sensitivity, , ... PCR is efficient sample preparation, as well as thermal ...
Cached Biology Technology:The use of TaqMaster PCR Enhancer 2The use of TaqMaster PCR Enhancer 3The use of TaqMaster PCR Enhancer 4The use of TaqMaster PCR Enhancer 5Enhancing PCR* Efficiency with MasterTaq 2Enhancing PCR* Efficiency with MasterTaq 3Enhancing PCR* Efficiency with MasterTaq 4Enhancing PCR* Efficiency with MasterTaq 5Efficient and Reliable PCR Setup Using Eppendorf MasterMix 2Efficient and Reliable PCR Setup Using Eppendorf MasterMix 3Efficient and Reliable PCR Setup Using Eppendorf MasterMix 4Efficient and Reliable PCR Setup Using Eppendorf MasterMix 5Efficient and Reliable PCR Setup Using Eppendorf MasterMix 6Efficient and Reliable PCR Setup Using Eppendorf MasterMix 7
(Date:8/4/2015)... 2015  AMRI (NASDAQ: AMRI ) today reported financial and ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 % ... a $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial ...
(Date:7/31/2015)... China , 31 de julho de 2015 /PRNewswire/ ... (ICG-10, www.icg-10.org ) será realizada pela BGI de 22-25 ... . A conferência está celebrando seu ... em 2006, a ICG se tornou uma das reuniões ... um dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... , Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market and ... has filed provisional patent 62/198989 for ELECTRONIC ... highlights a method to advance crypto-currencies such as Bitcoin ... a common, uniform way to manage all payments.  ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... Trust and the Arthritis Research Campaign has identified two ... disease primarily causing back pain and progressive stiffness. The ... a treatment currently being trialled for Crohn,s disease may ... affects as many as 1 in 200 men and ...
... with separate sexes, embryos commit to becoming male or female ... made by sex determination genes on the sex chromosomes. ... during evolution. In contrast, the sex determination genes and ... features of the genome. A research team formed ...
... partnership to build an integrated neuroscience research programme that ... Strategic research infrastructure for tertiary hospitals and medical ... late phase clinical trials in Singapore. These are ... the Biomedical Sciences International Advisory Council (BMS IAC) at ...
Cached Biology News:Major genetic breakthrough for ankylosing spondylitis brings treatment hope 2Major genetic breakthrough for ankylosing spondylitis brings treatment hope 3A new explanation for evolutionary changes in genetic sex-determination systems 2Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research 2Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research 3Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research 4Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research 5Phase 2 of Singapore's Biomedical Sciences Initiative gains momentum for clinical research 6
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
Tissue culture grade....
Mus musculus MARCKS-like protein, mRNA...
Biology Products: